Leaving his position as director of research at a drug-making company in New Jersey, Xian-Ping Lu took a big risk – he moved to China, where he spent more than 14 years developing a medicine that treats a rare lymph node cancer. The medical industry in China is growing with more and more drug developers taking advantage of an environment that fosters biomedical innovation. Lu’s patented cancer treatment, now approved for use in the U.S., is treating cancer patients across the globe.

Read more in the Wall Street Journal.